New press release out: HCS Pharma participates in the development of an improved biomimetic liver model on chip for drug discovery

HCS Pharma announces the closure of the “MIMLIVERonChip” project, funded by the French National Research Agency (ANR, project ANR 19 CE19-0020) and coordinated by BMBI Biomechanics and Bioengineering joint research unit (UTC/ CNRS), headed by Dr Cécile Legallais, CNRS research director. This project led to the publication of Taha Messelmani’s Read more…

Feedback of Rania’s internship about the development of primary human hepatocyte model in biochip microfludic system

This is the end of Rania‘s 6-month internship in HCS Pharma about a new liver biochip system. After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with the University of Technology of Compiègne (UTC) using the BIOMIMESYS® Liver hydroscaffold™ and HepG2/C3A (hepatocellular Read more…

HCS Pharma @ELRIG congress in Basel “Advancements in cell & gene therapy: new therapeutic horizons” on Friday, 15th september 2023

In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D hydroscaffold matrix BIOMIMESYS® could be useful for bioproduction and then for cell therapy. We will be happy to meet you at ELRIG congress “Advancements in cell & Read more…

New press release out: HCS Pharma, LumiSTAR Biotech & MolDev explore stem cell-derived organoids for drug screening

In Asia for a business trip, Nathalie Maubon, PhD, CEO & CSO of HCS Pharma, participated in a symposium during BioAsia event on late July, together with LumiSTAR Biotechnology (Taïwan) and Molecular Devices (USA). On this occasion, the 3 companies have highlighted their work on hiPSCs (human induced Pluripotent Stem Read more…

HCS Pharma is delighted to help Vidac Pharma in the fight against cancer

Rehovot (Israel) London (UK) and Lille (France) Vidac Pharma is a clinical stage biopharmaceutical company dedicated to discovering and developing First-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. Vidac Pharma and HCS Pharma announce cooperative agreement on acceleration of pre-clinical assays for Vidac Pharma Read more…

Avancées prometteuses dans la lutte contre le cancer : les projets innovants de HCS Pharma

Chez HCS Pharma, nous sommes ravis de partager avec vous les avancées significatives que nous avons réalisées dans nos projets de recherche et développement.  Avant de commencer, nous tenons à remercier “La Gazette du Laboratoire”  pour leur soutien continu et leur couverture détaillée de nos efforts.  Notre entreprise, basée à Read more…